GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

NCT04387201 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Glucose Intolerance
Overweight and Obesity
Drug Effect
Adiposity

Interventions

DRUG: Cyanocobalamin
DRUG: Dulaglutide

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]